Amerigen Pharmaceuticals

Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees

Amerigen Pharmaceuticals is a privately held pharmaceutical manufacturer focused on developing, manufacturing, and selling generic medicines for the United States and China. The U.S. operations are based in Lyndhurst, New Jersey, housing executive management and core functions such as product and business development, finance, regulatory affairs, and commercial operations, with product development conducted at locations around the world under the guidance of experienced R&D and regulatory leadership. The company’s main manufacturing facility is in Suzhou, Jiangsu Province near Shanghai, and this site is approved by both the U.S. FDA and the Chinese CFDA for finished-dose manufacturing, with local management supporting the Chinese market.

Amerigen maintains an active portfolio of products under development or filed for FDA ANDA consideration, while nine products are already approved for sale in China, with further opportunities being pursued for Chinese market expansion. The firm combines western-style management and quality assurance practices with manufacturing site approvals to supply high-quality, affordable medicines in the United States and China. In 2020, Amerigen transferred its U.S. portfolio of 23 generic products to ANI Pharmaceuticals.

Sign up for free to view info

Email Format Employee directory